Jul 2019 $10 M No. 11 $10 to $50 million 1
Castle Biosciences Inc.: Raise no. 11, Jul 2019 × Investors in this round 1 investor had bought by the notice of Jul 30, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $20 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bernhard E. Spiess · Executive Officer Derek Maetzold · Executive Officer, Director Federico E. Monzon, M.D., FCAP · Executive Officer Frank C. Stokes · Executive Officer Bonnie Anderson · Director Daniel M. Bradbury · Director David C. Kabakoff, Ph.D. · Director G. Bradley Cole · Director Joseph C. Cook, III · Director Mara Aspinall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount includes amounts receivable upon exercise of warrants to purchase shares of Common Stock (assuming no net exercise, where applicable). The warrants have not yet been exercised.”Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Jul 30, 2019. Read the notice at the SEC .
debt, options SEC May 2018 $5 M No. 10 $2 to $10 million 44
Castle Biosciences Inc.: Raise no. 10, May 2018 × Investors in this round 44 investors had bought by the notice of Jun 13, 2018: 44 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bernhard E. Spiess · Executive Officer Derek Maetzold · Executive Officer, Director Federico E. Monzon, M.D., FCAP · Executive Officer Frank C. Stokes · Executive Officer Bonnie Anderson · Director Daniel M. Bradbury · Director David C. Kabakoff, Ph.D. · Director Joseph C. Cook, Jr. · Director Mara Aspinall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Jun 13, 2018. Read the notice at the SEC .
equity SEC Jan 2018 $5 M No. 9 $2 to $10 million 48
Castle Biosciences Inc.: Raise no. 9, Jan 2018 × Investors in this round 48 investors had bought by the notice of Jan 19, 2018: 48 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bernhard E. Spiess · Executive Officer Derek Maetzold · Executive Officer, Director Federico E. Monzon, M.D., FCAP · Executive Officer Frank C. Stokes · Executive Officer Bonnie Anderson · Director Daniel M. Bradbury · Director David C. Kabakoff, Ph.D. · Director Joseph C. Cook, Jr. · Director Mara Aspinall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount includes amounts receivable by the Issuer upon exercise of warrants to purchase the Issuer's Preferred Stock.”Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Jan 19, 2018. Read the notice at the SEC .
equity, options SEC Jul 2015 $12 M No. 8 $10 to $50 million 17
Castle Biosciences Inc.: Raise no. 8, Jul 2015 × Investors in this round 17 investors had bought by the notice of Jul 30, 2015: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $12 M of $20 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director Bonnie Anderson · Director Daniel Bradbury · Director Garheng Kong · Director Joseph Cook, Jr. · Director Mara Aspinall · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Jul 30, 2015. Read the notice at the SEC .
equity SEC Aug 2014 $8 M No. 7 $2 to $10 million 4
Castle Biosciences Inc.: Raise no. 7, Aug 2014 × Investors in this round 4 investors had bought by the notice of Aug 18, 2014: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $8 M of $12 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director Daniel Bradbury · Director Joe Cook, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Aug 18, 2014. Read the notice at the SEC .
equity, options SEC Apr 2014 $1 M No. 6 Under $2 million 3
Castle Biosciences Inc.: Raise no. 6, Apr 2014 × Investors in this round 3 investors had bought by the notice of May 5, 2014: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director Daniel Bradbury · Director Joe Cook, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed May 5, 2014. Read the notice at the SEC .
equity, debt SEC Nov 2013 $1 M No. 5 Under $2 million 3
Castle Biosciences Inc.: Raise no. 5, Nov 2013 × Investors in this round 3 investors had bought by the notice of Nov 19, 2013: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director, Promoter Daniel Bradbury · Director Joe Cook, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Nov 19, 2013. Read the notice at the SEC .
equity, debt SEC May 2013 $2 M No. 4 Under $2 million 7
Castle Biosciences Inc.: Raise no. 4, May 2013 × Investors in this round 7 investors had bought by the notice of May 16, 2013: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director, Promoter Daniel Bradbury · Director Joe Cook, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed May 16, 2013. Read the notice at the SEC .
equity SEC Sep 2012 $1 M No. 3 Under $2 million 10
Castle Biosciences Inc.: Raise no. 3, Sep 2012 × Investors in this round 10 investors had bought by the notice of Oct 4, 2012: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director, Promoter Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Oct 4, 2012. Read the notice at the SEC .
equity SEC Sep 2011 $2 M No. 2 Under $2 million 4
Castle Biosciences Inc.: Raise no. 2, Sep 2011 × Investors in this round 4 investors had bought by the notice of Aug 5, 2014: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director Daniel Bradbury · Director Joe Cook, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Aug 5, 2014. Read the notice at the SEC .
equity SEC Mar 2010 $1 M No. 1 Under $2 million 6
Castle Biosciences Inc.: Raise no. 1, Mar 2010 × Investors in this round 6 investors had bought by the notice of Mar 12, 2010: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Castle Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Derek Maetzold · Executive Officer, Director, Promoter Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$195,001 of the aggregate offering amount has not and will not be received by the issuer until such time, if any, that the Warrants issued in this transaction are exercised.”Signed by Derek Maetzold, President and CEO. Source: SEC Form D, newest notice filed Mar 12, 2010. Read the notice at the SEC .
equity, debt, options SEC